Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4981 Sv-293
Selective D2 dopamine receptor antagonist
More description
DCC4980 suvanine
Antagonist of the mammalian bile acid sensor farnesoid-X-receptor (FXR)
More description
DCC4979 Supradamal
Potent Inhibitor of Plasmodium FK506 Binding Protein 35 (FKBD35), also act as a HIV inhibitor
More description
DCC4978 Sun-c5174
5-HT2 antagonist
More description
DCC4977 Sun13837
Novel fibroblast growth factor receptor modulator for treating neurodegenerative diseases
More description
DCC4976 Sumanirole
D2 selective dopamine agonist, showing anxiolytic and anti-parkinsonian activities
More description
DCC4975 Sulukast
Novel, potent, selective, and competitive antagonist of LTD4 and LTE4
More description
DCC4974 Suloctidil Hydrochloride
Peripheral vasodilator
More description
DCC4973 Sulfosuccinimidyl Oleate Sodium
Neuroprotective agent, alleviating stroke-induced neuroinflammation
More description
DCC4972 Sulfonyl Quinoxaline 1
Novel inhibitor of RhoG-hepcidin uptake
More description
DCC4971 Sulfazecin
β-Lactam antibiotic against multi-drug resistant pathogens
More description
DCC4970 Sulfacetamide
Antibacterial, inhibiting bacterial folic acid synthesis by competing with para amino benzoic acid
More description
DCC4969 Sul-121 Hydrochloride
Novel inhibitor of airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease (COPD)
More description
DCC4968 Suku-33
Novel potent inhibitor of osteoclastogenesis, suppressing both equilibrative nucleoside transporters and concentrative nucleoside transporters
More description
DCC4966 Suc-leu-leu-val-tyr-amc
Fluorescent substrate which can be hydrolyzed by the proteasome to release free AMC and the fluorescence of which is proportional to the proteasome activity
More description
DCC4965 Subglutinol A
Natural immunosuppressive agent, effectively blocking T cell proliferation and survival while profoundly inhibiting pro-inflammatory IFNγ and IL-17 production by fully differentiated effector Th1 and Th17 cells, also acting as an estrogen receptor antagon
More description
DCC4964 Su9518
Novel potent and selective inhibitor of the cellular PDGF receptor kinase and PDGF receptor-induced cell proliferation
More description
DCC4963 Su-200
Agonist of TRPV1
More description
DCC4962 Su11652
Sunitinib analog, acting as a potential inhibitor for nucleoside diphosphate kinase (NDK) from Leishmania major (LmNDK)
More description
DCC4961 Su11606
Potent c-MET inhibitor
More description
DCC4960 Su11272
Novel potent c-MET inhibitor
More description
DCC4959 Su0383
Novel dual Inhibitor of repair enzymes 8-oxoguanine DNA glycosylase (OGG1) and human MutT Homolog 1 (NUDT1 or MTH1), increasing sensitivity of tumor cells to oxidative stress
More description
DCC4958 Stx2845
Novel Nonsteroidal Inhibitor of Carbonic Anhydrase IX
More description
DCC4957 Stx-2622
Inhibitor of 17β-hydroxysteroid dehydrogenases (17β-HSDs)
More description
DCC4956 Sts-e424
Novel agonist of the tissue-protective erythropoietin (EPO) receptor, increasing FXN expression and EPOR phosphorylation
More description
DCC4955 Sts-e412
The first nonpeptidyl, selective activator of the tissue-protective EPOR/CD131 receptor
More description
DCC4954 Streptozocin
Antibiotic, being used as an antineoplastic agent and to induce diabetes in experimental animals
More description
DCC4953 Streptolidine
Metablite of the Streptomyces antibiotics streptothricin and streptolin
More description
DCC4952 Stock1n-65837
Potent natural modulator of human Toll-like receptor 7 (TLR7)
More description
DCC4951 Stk683963
Novel activator of cellular ATG4B activity
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X